Baseline neutrophil-lymphocyte ratio (NLR) predicts toxicity and survival in HR+/HER-2 breast cancer patients treated with CDK4/6 inhibitors.

Breast · 2025 · PMC12446499 · PMID 40907238

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

This pattern held across multiple stratifications of neutrophil count, revealing a clear trend: patients with lower absolute neutrophil counts following treatment were more likely to have presented with higher baseline NLR.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.